ALLIEVEX
Allievex is a clinical-stage biotechnology company
ALLIEVEX
Social Links:
Industry:
Biotechnology
Founded:
2018-01-01
Address:
Marblehead, Massachusetts, United States
Country:
United States
Website Url:
http://www.allievex.com
Total Employee:
11+
Status:
Active
Similar Organizations
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
Illustris Pharmaceuticals
Illustris is a clinical-stage biodevelopment company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Medicell Technologies
MediCell Technologies is a biotechnology company.
NanOlogy
NanOlogy™ is a clinical-stage oncology company
Vivid Biosciences
Vivid Biosciences is a clinical-stage biotechnology company.
Current Advisors List
Investors List
Novo Holdings
Novo Holdings investment in Series A - Allievex
Pappas Capital
Pappas Capital investment in Series A - Allievex
Official Site Inspections
http://www.allievex.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Allievex"
Our Team - Allievex
The Allievex management team offers a unique skillset and proven track record of excellence in therapeutic development for neurological diseases.See details»
Allievex - Crunchbase Company Profile & Funding
Allievex has 2 investors including Novo Holdings and Pappas Capital. When was the last funding round for Allievex? Allievex closed its last funding round on …See details»
Partners - Pappas Capital
In 2019, Tom founded Allievex Corp., a Pappas Ventures V portfolio company, and served as its President and CEO, as well as a director, until 2024. ... as a member of the Emerging …See details»
Tom Mathers - Pappas Capital
In 2019, Tom founded Allievex Corp., a Pappas Ventures V portfolio company, and served as its President and CEO, as well as a director, until 2024. ... as a member of the Emerging …See details»
Allievex - Pappas Capital
Allievex is a clinical‐stage biotechnology company founded by Pappas Capital that is developing novel therapies for the treatment of rare pediatric neurodegenerative diseases. Allievex’s lead …See details»
Allievex Corp. Company Profile | Marblehead, MA | Competitors ...
Find company research, competitor information, contact details & financial data for Allievex Corp. of Marblehead, MA. Get the latest business insights from Dun & Bradstreet.See details»
Allievex Company Profile - Office Locations, Competitors ... - Craft
Allievex is a company building a portfolio of therapeutics for the treatment of rare pediatric neurodegenerative diseases. It develops tralesinidase alfa for the treatment of children with …See details»
Allievex - Org Chart, Teams, Culture & Jobs - The Org
View Allievex's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. Log in. Sign up. Allievex. Join to edit. Join to …See details»
Allievex - Contacts, Employees, Board Members, Advisors & Alumni
Allievex is a clinical-stage biotechnology company. Start Free Trial . Chrome ExtensionSee details»
Allievex - Funding, Financials, Valuation & Investors - Crunchbase
Oct 23, 2019 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Oct 23, 2019: …See details»
Allievex 2025 Company Profile: Valuation, Funding & Investors
Allievex General Information Description. Developer of novel therapies designed for the treatment of rare pediatric neurodegenerative diseases. The company's therapy is an investigational …See details»
Investors & Media - Allievex
Jan 26, 2021 Allievex is planning to expand its investor syndicate with Series B financing. Read more about Allievex news, events and publications here.See details»
Allievex Corporate Headquarters, Office Locations and Addresses
Allievex Headquarters and Office Locations. Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit. Button CTA. Allievex is headquartered in Marblehead, United …See details»
Allievex Corporation: Revenue, Worth, Valuation & Competitors 2025
Allievex Corporation has an estimated revenue of $542.5K, and 7 employees. Alternatives of Allievex Corporation are Dermavant Sciences, Metrum Researc...See details»
Partner With Us - Allievex
Allievex is committed to partnering with innovators in the fight against devastating rare neurological diseases of childhood. Our pipeline is largely based on collaborations and …See details»
Spruce Bio announced acquisition of AX 250 ERT for Sanfilippo …
Apr 15, 2025 Spruce Biosciences has acquired Allievex’s tralesinidase alfa ERT (previously AX 250) for the treatment of Sanfilippo Type B (MPS IIIB). Spruce has publicly announced its …See details»
Allievex | Patient & Caregiver Resources
Allievex has no affiliations with the organizations listed on this page, but we share them as a resource to those affected by Sanfilippo syndrome and other rare diseases. ... The World …See details»
Allievex – Rock Creek
Allievex is a clinical-stage biopharmaceutical company dedicated to developing therapies for rare pediatric neurodegenerative diseases. Their lead product candidate, tralesinidase alfa, is an …See details»
Allievex Completes Series A Financing – Investocracy News
Oct 23, 2019 Allievex has successfully closed its first investment round and Tom has assembled an experienced team of biotech veterans with deep knowledge of the drug development …See details»
Clinicians & Access - Allievex
Allievex is focused on gaining regulatory approvals to make our therapies broadly available to patients as quickly as possible. Clinical trials are key research tools for advancing medical …See details»